Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

Insiders Menu
Roster
Transactions
GENELUX Corp

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
10/05/2023Szalay Aladar10% OwnerSaleCommon Stock13.3k$24.89$330.1kBy Trust10/05/2023
10/05/2023Szalay Aladar10% OwnerSaleCommon Stock985$25.47$25.1kBy Trust10/05/2023
10/03/2023Szalay Aladar10% OwnerSaleCommon Stock75.7k$25.49$1.9MBy Trust10/03/2023
10/02/2023Jewett CarolineHead of QualityGrantStock Option (right to buy)22k$24.75$544.5k 10/02/2023
09/28/2023Szalay Aladar10% OwnerSaleCommon Stock2.3k$24.12$55.2kBy Trust09/27/2023
09/27/2023Szalay Aladar10% OwnerSaleCommon Stock11.3k$24.47$275.5kBy Trust09/27/2023
09/26/2023Szalay Aladar10% OwnerSaleCommon Stock9.6k$24.51$235.3kBy Trust09/25/2023
09/26/2023Szalay Aladar10% OwnerSaleCommon Stock12.7k$24.03$306.1kBy Trust09/25/2023
09/26/2023Szalay Aladar10% OwnerSaleCommon Stock7.5k$22.47$167.7kBy Trust09/25/2023
09/26/2023Yu TonyVP, Clinical Trial OperationsExerciseStock Option (right to buy)5.2k$6.00$31.2k 09/26/2023
09/26/2023Yu TonyVP, Clinical Trial OperationsSaleCommon Stock2.2k$24.46$53.9k 09/26/2023
09/26/2023Yu TonyVP, Clinical Trial OperationsSaleCommon Stock1.1k$23.51$26.2k 09/26/2023
09/26/2023Yu TonyVP, Clinical Trial OperationsSaleCommon Stock1.9k$22.54$42.4k 09/26/2023
09/25/2023Szalay Aladar10% OwnerSaleCommon Stock1.1k$27.81$30.6kBy Trust09/25/2023
09/25/2023Szalay Aladar10% OwnerSaleCommon Stock1.9k$26.60$50.5kBy Trust09/25/2023
09/25/2023Szalay Aladar10% OwnerSaleCommon Stock5.5k$25.75$141.9kBy Trust09/25/2023
09/25/2023Szalay Aladar10% OwnerSaleCommon Stock3.9k$24.82$98kBy Trust09/25/2023
08/18/2023Yu TonyVP, Clinical Trial OperationsSaleCommon Stock3.3k$23.73$77.5k 08/18/2023
08/18/2023Zindrick ThomasPresident and CEOSaleCommon Stock8.3k$23.73$198.1k 08/18/2023
08/18/2023Cappello JosephVP, Pharmaceutical DevelopmentSaleCommon Stock3.3k$23.73$77.5k 08/18/2023
08/18/2023Jewett CarolineHead of QualitySaleCommon Stock515$23.73$12.2k 08/18/2023
08/18/2023Ryder SeanGeneral CounselSaleCommon Stock328$23.73$7.8k 08/18/2023
08/18/2023Samuelson DougCFOSaleCommon Stock1.3k$23.73$30.8k 08/18/2023
08/18/2023Smalling RalphHead of RegulatorySaleCommon Stock935$23.73$22.2k 08/18/2023
02/17/2023Cappello JosephVP, Pharmaceutical DevelopmentGrantCommon Stock9k$0.00$0 02/17/2023
02/17/2023Mirabelli MaryDirectorGrantCommon Stock1000$0.00$0 02/17/2023
02/17/2023Woodward GabeDirectorGrantCommon Stock1000$0.00$0 02/17/2023
02/17/2023Ryder SeanGeneral CounselGrantCommon Stock900$0.00$0 02/17/2023
02/17/2023Zhang QianAssociate VP, ResearchGrantCommon Stock6k$0.00$0 02/17/2023
02/17/2023Yu TonyVP, Clinical Trial OperationsGrantCommon Stock9k$0.00$0 02/17/2023
01/30/2023Woodward GabeDirectorConversionCommon Stock5.4k$0.00$0By Olympic Xploration01/30/2023
01/30/2023Szalay Aladar10% OwnerConversionCommon Stock500k$0.00$0By Trust01/30/2023
01/30/2023Szalay Aladar10% OwnerConversionCommon Stock500k$0.00$0By Trust01/30/2023
01/30/2023Szalay Aladar10% OwnerConversionSeries A Preferred Stock1.5M$0.00$0By Trust01/30/2023
01/30/2023Szalay Aladar10% OwnerConversionSeries A Preferred Stock1.5M$0.00$0By Trust01/30/2023
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy